ELAB

Elevai Labs, Inc.

2.41

Top Statistics
Market Cap 7 M Forward PE 0.0000 Revenue Growth 91.30 %
Current Ratio 1.05 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -192.08 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.1190 Enterprise / Revenue 0.2300 Price To Sales Trailing12 Months 2.99
Profitability
Profit Margins -192.08 % Operating Margins -231.53 %
Balance Sheet
Total Cash 100034 Total Cash Per Share 0.0050 Total Debt 140063
Total Debt To Equity 5.31 Current Ratio 1.05 Book Value Per Share 0.2210
All Measures
Short Ratio 17.00 % Message Board Id finmb_1683617420 Shares Short Prior Month 686391
Return On Equity -3.51 City Newport Beach Uuid 5c695af1-36eb-364e-86db-fbf1f5ae6ba9
Previous Close 2.50 First Trade Date Epoch Utc 1 B Book Value 0.2210
Total Debt 140063 Volume 903957 Price To Book 10.90
Last Split Date 1 B Fifty Two Week Low 2.04 Total Cash Per Share 0.0050
Total Revenue 2 M Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins -231.53 % Net Income To Common -4750704
Short Percent Of Float 0.2228 Implied Shares Outstanding 517 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 2 M Average Volume10days 2 M
Total Cash 100034 Next Fiscal Year End 1 B Revenue Per Share 0.1680
Held Percent Insiders 0.7298 Ebitda Margins -193.37 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 2.50
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 14.99
Open 2.34 Free Cashflow -3571104 State CA
Dividend Yield 0.00 % Return On Assets -0.8855 Time Zone Short Name EST
Trailing Eps -88.92 Day Low 2.04 Address1 120 Newport Center Drive
Shares Outstanding 3 M Price Hint 4 Target High Price 0.0000
Website https://elevaiskincare.com 52 Week Change -0.9957 Average Volume 684791
Recommendation Key none Forward Eps 0.0000 Compensation As Of Epoch Date 1 B
Quick Ratio 6.70 % Last Split Factor 1:200 Regular Market Day High 2.60
Is_sp_500 False Profit Margins -192.08 % Debt To Equity 5.31
Fifty Two Week High 778.00 Day High 2.60 Shares Short 9 M
Regular Market Open 2.34 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue 0.2300 Revenue Growth 91.30 % Shares Percent Shares Out 0.1908
Operating Cashflow -6007306 Currency USD Time Zone Full Name America/New_York
Market Cap 7 M Is_nasdaq_100 False Zip 92660
Quote Type EQUITY Industry Biotechnology Long Name Elevai Labs Inc.
Regular Market Day Low 2.04 Held Percent Institutions 0.1820 Current Price 2.41
Address2 Suite 250 Enterprise To Ebitda -0.1190 Financial Currency USD
Current Ratio 1.05 Gross Margins 69.25 % Industry Disp Biotechnology
Country United States Float Shares 16 M Two Hundred Day Average 88.44
Enterprise Value 569062 Price To Sales Trailing12 Months 2.99 Forward PE 0.0000
Regular Market Volume 903957 Ebitda -4782589 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States.

The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions.

It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare.

The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021.

Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.